Credits Available: 4.25 AMA PRA Category 1 Credits™, 4.25 ANCC Contact Hours, 4.25 ACPE

Description: This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell treatment; and the delivery of goal-concordant care using shared decision-making strategies. A challenging real-world case scenario discussion within each Gather-ed group highlights critical decision points, key challenges, and opportunities to incorporate collective insights.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Pharmacist, Physician Assistant, Nurse, Pharmacy Director
Target Specialties: Hematology, Hematology/Oncology, Oncology

Sven de Vos

UCLA Health

Dr. Sven de Vos is a hematologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including UCLA Medical Center and UCLA Santa Monica Medical Center. He received his medical degree from Eberhard Karls University Faculty of Medicine and has been in practice for more than 20 years. Dr. Sven Devos has expertise in treating lymphoma, chronic leukemia, prostate cancer, among other conditions - see all areas of expertise. Dr. Sven Devos accepts Medicare, Aetna, Blue Cross, United Healthcare - see other insurance plans accepted. Dr. Sven Devos is highly recommended by patients.